GRx+Biosims is the Association for Accessible Medicines' (AAM) flagship regulatory, science and policy event for the US generics and biosimilars industry. The 2026 edition runs 2-4 November at the Bethesda North Marriott Hotel & Conference Center in Rockville, Maryland, bringing FDA experts together with industry for three days of sessions and networking.
Dates and venue
- Dates: 2-4 November 2026
- Venue: Bethesda North Marriott Hotel & Conference Center, Rockville, Maryland, USA
- Organizer: Association for Accessible Medicines (AAM)
Who should attend
GRx+Biosims is built around the regulatory and policy mechanics specific to generic and biosimilar products — ANDA strategy, biosimilar interchangeability, GDUFA/BsUFA user-fee programs and FDA's current thinking, direct from its own staff. It suits regulatory affairs and policy professionals at generic and biosimilar manufacturers, along with legal and government-affairs teams tracking the competitive and legislative landscape around follow-on products.
Working the broader drug-development calendar that autumn? AAPS PharmSci 360 runs in New Orleans the week before, and the full events directory lists everything we have verified. Every listing is checked the same way.
Frequently asked questions
When is GRx+Biosims 2026?
2-4 November 2026, at the Bethesda North Marriott Hotel & Conference Center in Rockville, Maryland. Dates are published on AAM's own event page, last confirmed on 4 October 2026.
Where is GRx+Biosims 2026 being held?
The Bethesda North Marriott Hotel & Conference Center in Rockville, Maryland, USA.
How much does GRx+Biosims 2026 cost?
AAM had not published 2026 registration pricing on its own pages as of 4 October 2026. We do not list prices taken from third-party sites, so check the official AAM registration page for current rates.
Is GRx+Biosims 2026 in person or virtual?
It is held at a physical hotel venue in Rockville, Maryland, with in-person exhibitor meetings described as a core feature. AAM does not state on its own pages whether a virtual or hybrid option is offered, so confirm with the organizer if you need to attend remotely.
Who should attend GRx+Biosims?
Regulatory, scientific and policy professionals working in the US generics and biosimilars industry, including those tracking FDA guidance, ANDA and biosimilar approval pathways and related legal and policy developments.
Sources & further reading
- Association for Accessible Medicines. GRx+Biosims 2026 — event page, 2-4 November 2026. accessiblemeds.org
- 10times.com. GRx+Biosims (Nov 2026), Rockville USA — conference listing. 10times.com
Event details are published by the organizer and can change. This listing was corroborated via web search rather than a direct fetch of the organizer's page (network egress was blocked this session); confirm dates, venue, format and pricing with AAM before booking travel. Last verified 4 October 2026.